We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+15.21%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$436B
AUM Growth
+$83.7B
Cap. Flow
+$35.4B
Cap. Flow %
8.11%
Top 10 Hldgs %
42.78%
Holding
5,681
New
461
Increased
2,914
Reduced
1,346
Closed
463

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.6B
2
AVGO icon
Broadcom
AVGO
+$1.11B
3
QQQ icon
Invesco QQQ Trust
QQQ
+$882M
4
JPM icon
JPMorgan Chase
JPM
+$628M
5
TSLA icon
Tesla
TSLA
+$594M

Sector Composition

Rank Sector Weight
1 Technology 19.83%
2 Financials 7.37%
3 Consumer Discretionary 6.6%
4 Communication Services 5.05%
5 Healthcare 4.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLXE icon
4901
KLX Energy Services
KLXE
$46M
$1.25K ﹤0.01%
667
-54
-7% -$112
CAPL icon
4902
CrossAmerica Partners
CAPL
$862M
$1.21K ﹤0.01%
+58
New +$1.3K
SNTI icon
4903
Senti Biosciences Holdings
SNTI
$10.9M
$1.2K ﹤0.01%
569
+539
+1,797% +$1.71K
PHI icon
4904
PLDT
PHI
$4.25B
$1.18K ﹤0.01%
54
RDFN
4905
PUT
DELISTED
Redfin
RDFN
$1.12K ﹤0.01%
+100
New +$981
ESGU icon
4906
iShares ESG Aware MSCI USA ETF
ESGU
$18.4B
$1.08K ﹤0.01%
8
SST icon
4907
System1
SST
$17.8M
$1.05K ﹤0.01%
190
-2,990
-94% -$13.3K
VLRS
4908
Controladora Vuela Compania de Aviacion
VLRS
$927M
$1.04K ﹤0.01%
+220
New +$985
THTX
4909
DELISTED
Theratechnologies
THTX
$944 ﹤0.01%
+400
New +$980
HLVX
4910
DELISTED
HilleVax
HLVX
$894 ﹤0.01%
449
-31,670
-99% -$57.9K
BRAG
4911
Bragg Gaming Group
BRAG
$51.2M
$864 ﹤0.01%
200
JFIN
4912
Jiayin Group
JFIN
$131M
$769 ﹤0.01%
48
-271,077
-100% -$3.68M
RPTX
4913
DELISTED
Repare Therapeutics
RPTX
$737 ﹤0.01%
530
-75
-12% -$98
BITO icon
4914
ProShares Bitcoin Strategy ETF
BITO
$1.44B
$710 ﹤0.01%
33
-37
-53% -$763
NA
4915
Nano Labs
NA
$42M
$705 ﹤0.01%
76
GHI icon
4916
Greystone Housing Impact Investors LP
GHI
$135M
$645 ﹤0.01%
57
+48
+533% +$562
TSAT icon
4917
Telesat
TSAT
$864M
$611 ﹤0.01%
25
ADAP
4918
DELISTED
Adaptimmune Therapeutics
ADAP
$608 ﹤0.01%
2,534
-47,534
-95% -$12.7K
EPIX
4919
DELISTED
ESSA Pharma
EPIX
$604 ﹤0.01%
355
IPHA
4920
Innate Pharma
IPHA
$208M
$557 ﹤0.01%
307
EBON icon
4921
Ebang International Holdings
EBON
$13M
$531 ﹤0.01%
161
EQNR icon
4922
Equinor
EQNR
$97.4B
$503 ﹤0.01%
+20
New +$484
TCRT icon
4923
Alaunos Therapeutics
TCRT
$4.84M
$485 ﹤0.01%
100
-71
-42% -$214
NUVB.WS
4924
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$442 ﹤0.01%
1,638
LYRA
4925
DELISTED
LYRA THERAPEUTICS INC
LYRA
$430 ﹤0.01%
48
-953
-95% -$7.91K

Similar funds

Barclays's Q2 2025 Portfolio in Review

As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.

  • Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
  • Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
  • Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
  • Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
  • Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
  • Barclays opened 461 new positions and closed 463 in Q2 2025.
  • Barclays's portfolio value rose 24% quarter-over-quarter to $436B.

Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.